1. Home
  2. SPRO vs INTG Comparison

SPRO vs INTG Comparison

Compare SPRO & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPRO

Spero Therapeutics Inc.

N/A

Current Price

$1.14

Market Cap

71.0M

Sector

Health Care

ML Signal

N/A

Logo Intergroup Corporation (The)

INTG

Intergroup Corporation (The)

N/A

Current Price

$36.50

Market Cap

76.2M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
INTG
Founded
2013
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
76.2M
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
SPRO
INTG
Price
$1.14
$36.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
355.5K
88.8K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
N/A
0.67
Revenue
$66,802,000.00
$74,753,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
N/A
P/E Ratio
N/A
$53.64
Revenue Growth
39.24
4.43
52 Week Low
$1.08
$16.88
52 Week High
$3.08
$52.00

Technical Indicators

Market Signals
Indicator
SPRO
INTG
Relative Strength Index (RSI) 32.01 50.98
Support Level $1.13 $35.80
Resistance Level $1.29 $38.38
Average True Range (ATR) 0.04 2.32
MACD 0.01 0.24
Stochastic Oscillator 15.53 46.11

Price Performance

Historical Comparison
SPRO
INTG

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About INTG Intergroup Corporation (The)

The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.

Share on Social Networks: